Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-27T20:10:01.968Z Has data issue: false hasContentIssue false

Proposal of a therapeutic algorithm for the psychopharmacological management of treatment-resistant depression

Published online by Cambridge University Press:  01 September 2022

A. Sanz Giancola*
Affiliation:
Hospital Universitario Príncipe de Asturias, Psychiatry, Alcalá de Henares, Spain
M.D.C. Molina Liétor
Affiliation:
Hospital Universitario Príncipe de Asturias, Psychiatry, Alcalá de Henares, Spain
I. Cuevas Iñiguez
Affiliation:
Hospital Universitario Príncipe de Asturias, Psychiatry, Alcalá de Henares, Spain
C. Alvarez Garcia
Affiliation:
Hospital Universitario Príncipe de Asturias, Psychiatry, Alcalá de Henares, Spain
M. Blanco Prieto
Affiliation:
Hospital Universitario Príncipe de Asturias, Psychiatry, Alcalá de Henares, Spain
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

The lack of a standardised definition for the concept of TRD and an adequate criteria for therapeutic response make difficult the management of patients with MDD who do not achieve remission with one or more courses of treatment. All classifications suggested to define TRD are arbitrary, partially evidence-based, subordinated to the pharmacological findings of the time in which they are written and with serious inconsistencies, making it difficult to construct a universal and enduring diagnostic system.

Objectives

Considering that the most important goal in treating a patient with Major Depressive Disorder (MDD) should be remission and return to previous functionality, the search for a standardised, evidence-based classification system will allow timely and effective interventions leading to the reduction of this devastating condition.

Methods

Bibliographic review

Results

The proposed therapeutic algorithm arises from the combination of several fundamental principles for the management of treatment-resistant depression: the different classification systems of the concept, as well as the concepts of response, relapse, recurrence and remission; the scientific evidence found in the current literature, routine clinical practice, knowledge of switching and augmentation strategies, the new pharmacological targets and neurobiological hypothesis discovered, without forgetting finally the different clinical profiles of depressive symptomatology and the specific indications of each antidepressant.

Conclusions

Resistant depression is difficult to treat successfully and is not a uniform entity. Recently there has been a move to characterise treatment-resistant depression as ‘difficult-to-treat’ depression on the basis that the former description implies that depression treatments are normally effective and that non-response is therefore somehow abnormal.

Disclosure

No significant relationships.

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.